a pilot factorial trial of an integrated lifestyle intervention

Conditions: Physical Inactivity; Overweight and Obesity

Summary: this study plans to learn more about the feasibility and acceptability of integrating the move physical activity support program within an existing lifestyle intervention program.


Eligibility criteria:
inclusion criteria: * for all types of research participants: * men and women * age 18-65 years * have access to a computer and/or smart phone, and wi-fi * speak english (since all study materials are in english and the intervention will be delivered in a group-class setting with a coach who speaks english, we are only able to accommodate english-speakers at this time) * for the patient participants only: * body mass index 25-45 kg/m2 * insufficiently active (defined as \<150 min/week of voluntary exercise at moderate intensity over the past 3 months) * willing not to enroll in any other formal weight loss, or physical activity program over the next 5 months. * have a primary care physician (or has access to a healthcare professional and/or are willing to establish care with a primary care physician prior to study enrollment) to address medical issues which may arise during screening or study procedures/interventions. * capable and willing to give informed consent, understand exclusion criteria, attend the move program sessions, and complete outcome measures. * for the provider participants only: * \>1 year experience with delivering lifestyle interventions involving changes in diet and/or exercise behaviors. exclusion criteria: * for patient participants: * considered high risk, based on the american college of sports medicine guidelines for exercise testing and prescription (i.e. have cardiovascular disease symptoms or known cardiovascular disease, diabetes, or end-stage renal disease). * females who are currently pregnant or lactating, were pregnant within the past 3 months, or planning to become pregnant in the next 5 months will also be excluded * self-reported cardiovascular disease: * cardiac, peripheral vascular, or cerebrovascular disease * self-reported symptoms suggestive of cardiovascular disease: pain, discomfort in the chest, neck, jaw, arms, or other areas that may result from cardiac ischemia; shortness of breath at rest or with mild exertion; dizziness or syncope; orthopnea or paroxysmal nocturnal dyspnea; ankle edema; palpitations or tachycardia; intermittent claudication * self-reported end-stage renal disease * self-reported diabetes (history of type 1 or type 2 diabetes) * uncontrolled hypertension, defined as diastolic blood pressure \>100 mmhg, systolic blood pressure \>160 mmhg, or resting heart rate \>100 bpm as measured in duplicate at the screening visit after 5 minutes of rest in a seated position. * self-reported pulmonary disease requiring chronic oxygen supplementation; severe asthma or chronic obstructive pulmonary disease requiring hospitalization in past year. * plans to relocate in the next 16 months * currently participating in or planning to participate in any formal weight loss, dietary modification, or physical activity/exercise programs or clinical trials. * current severe depression or history of severe depression within the previous year, based on diagnostic and statistical manual of mental disorders, 4th edition, text revision (dsm-iv-tr) criteria for major depressive episode. score \> 18 on beck depression inventory (bdi) will require further assessment by the study medical doctor (md) to determine if it is appropriate for the subject to participate in the study. * history of other significant psychiatric illnesses (e.g., psychosis, schizophrenia, mania, bipolar disorder) which in the opinion of the study md would interfere with ability to adhere to the exercise intervention. * history of clinically diagnosed eating disorders including anorexia nervosa, bulimia, binge eating disorder. score \>20 on the eating attitudes test (eats-26) or pattern of response on the questionnaire on eating and weight patterns-5 (qewp-5) suggestive of possible binge eating disorder or bulimia will require further assessment by the study md to determine if it is appropriate for the subject to participate in the study. * current alcohol or substance abuse * nicotine use (current or past 6 months) * regular use of prescription or over-the-counter medications known to significantly impact appetite, weight, sleep, or energy metabolism (e.g., appetite suppressants, lithium, stimulants, anti-psychotics, tricyclic antidepressants) * regular use of obesity pharmacotherapeutic agents within the last 6 months. * previous obesity treatment with surgery or weight loss device, except: (1) liposuction and/or abdominoplasty if performed \> 1 year before screening, (2) lap banding if the band has been removed \> 1 year before screening, (3) intragastric balloon if the balloon has been removed \> 1 year before screening (4) duodenal-jejunal bypass sleeve, if the sleeve has been removed \> 1 year before screening or 5) aspireassist or other endoscopically placed weight loss device if the device has been removed \> 1 year before screening. * currently has access to and uses a fitness membership (defined as having used membership within the past month) * for provider participants: * none

Keywords: physical activity obesity weight loss nutrition diet lifestyle intervention